Tourmaline Bio Inc. (TRML)
Market Closed
28 Oct, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary NASDAQ (NGS) $
47. 98
0
0%
$
- Market Cap
- P/E Ratio
6.05% Div Yield
783,730 Volume
- Eps
$ 47.98
Previous Close Want to track TRML and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Tourmaline Bio Inc. (TRML) Statistics
Valuation metrics
Market Cap -
Enterprise value 1.2B
Trailing P/E (ttm) -26.8
Forward P/E -
PEG ratio 0.78
Price/Sales (ttm) -
Price/Book (mrq) 4.77
Enterprise Value/Revenue -
Enterprise Value/EBITDA -24.55
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 11.56
52-Week high 48.27
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 20 Oct 2023
Ex-Dividend Date 20 Oct 2023
Last split factor 1:10
Last split Date 20 Oct 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.17%
Return on equity -0.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.79
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.29
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 24.68%
Book value per share (mrq) 10.06
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
